Site hosted by Angelfire.com: Build your free website today!

 

CANCER

 

Cancer is new growth of tissue resulting from a continuous proliferation of abnormal cells that have the ability to invade and destroy other tissues. Cancer, which may arise from any type of cell and in any body tissue, is not a single disease but a large number of diseases classified according to the tissue and type of cell of origin. Several hundred such classes exist, constituting three major subtypes:

Sarcomas arise from connective and supportive tissue, such as bone, cartilage, nerve, blood vessels, muscle and fat. Carcinomas, which include the most frequently occurring forms of human cancer, arise from epithelial tissue, such as the skin and the lining of the body cavities and organs and the glandular tissue of the breast and prostate. Carcinomas with a structure resembling skin are termed squamous-cell carcinomas. Those that resemble glandular tissue are called adenocarcinomas. Leukaemias and lymphomas include the cancers that involve blood-forming tissue and are typified by the enlargement of the lymph nodes, the invasion of the spleen and bone marrow and the overproduction of immature white cells.

 

Prognosis and the Long-Term Picture

Many people are now successfully treated for cancer. The modern approach to cancer treatment also includes an emphasis on the patient's quality of life—both physical and mental. It is estimated that more than five million living Americans have had cancer: three million have survived more than five years and nearly all the survivors can be regarded as cured. There are many forms of cancer where the chances of survival are many times better than they were just a few years ago. The field of children's cancers is perhaps the most encouraging. For instance, nine out of ten children recover from Hodgkin's disease, but 30 years ago only about half survived. Other forms of cancer such as non-Hodgkin's disease and some leukaemias can be successfully treated as can certain forms of non-invasive bladder cancer, which if detected early can be contained over a period of several years.

 

The death rate from cancer has fallen progressively in people under 50 probably because healthier habits and environment have reduced prolonged exposure to carcinogens. Earlier diagnosis, which is absolutely vital in all cases and improved treatments are also involved. This drop is expected to extend to older age groups as these younger people age.

 

Decreases in the number of smokers in some countries are starting to have an impact on the cancer figures. Scottish women have the highest rate of death from lung cancer in the world. The overall risk of death from cancer has increased over the past 30 years. This is because cancer is mainly a disease of older age and as we become more successful at preventing early deaths from other illnesses such as heart attacks more people are living long enough to reach an age where their cancer risk is higher.

How Cancer Occurs

Cancer is a multi-stage process where a series of irreversible genetic errors occur in a cell in the body during a patient's lifetime. The early stages are critical for setting the process off. Later changes lead to spread and increased growth rate and are triggered by a range of external factors known as promotors. These errors may happen because the person has been exposed to cancer-causing agents (carcinogens). For instance cigarette smoke contains many chemical initiators and promotors.

 

In some people, however, there are also inherited gene defects which can give a potential cancerous cell a head start. Genes are made of DNA and are found in the center of the cell in structures known as chromosomes. Humans have 23 pairs of chromosomes and over 50,000 genes. If a chromosome is likened to a book each gene is a paragraph; a fault in a gene may be likened to a misprint.

 

Every time a cell divides a copy is made of the DNA. Sometimes an error occurs and a new cell ends up with an altered gene—a mutation. If the mutation occurs in a gene which normally controls cell growth, that cell may acquire the potential to become a cancer cell.

 

A cancerous growth or neoplasm is therefore clonal—that is, all its cells are descendants of a single cell. These cells have escaped the control of the normal forces regulating cellular growth. Resembling embryonic cells they are unable to differentiate or mature into an adult functioning state. As these cells multiply, they may form a mass called a tumor, which enlarges and continues to grow without regard to the function of the tissue of origin.

 

The body has ways of fighting back against mutations and a number of faults has to accumulate before a tumor develops. This can take a long time, which is why cancer is mainly a disease of older people; for instance 95% of bowel cancers occur in those over 50.

 

Tumors

Almost all cancers form tumors, but not all tumors are cancerous or malignant; the greatest number are benign. Benign tumors are characterized by entirely localized growth and are usually separated from neighboring tissue by a surrounding capsule. Benign tumors generally grow slowly and in structure closely resemble the tissue of origin. In some instances they may endanger the patient by obstructing, compressing or displacing neighboring structures as in the brain. A few benign tumors such as polyps of the colon may be precancerous.

Invasion and Spreading

The most significant attribute of malignant tumors is their ability to spread beyond the site of origin. Cancer may invade neighboring tissues by direct extension or infiltration or it may disseminate to distant sites forming secondary growths known as metastases. The routes and sites of metastases vary with different primary cancers:

 

(1) When a cancer extends through the surface of the organ of origin into a cavity, cells may break away from the surface and become implanted on the surface of adjacent organs.

 

(2) Tumor cells may migrate into the lymphatic channels and be carried to the draining lymph nodes or they may penetrate the blood vessels. Once in the bloodstream the tumor cells are carried to the point at which the vessels become too small for the large tumor cells to pass. Cells from tumors of the gastrointestinal tract will be stopped in the liver. Later they may go on to the lungs. Cells from all other tumors will go to the lungs before being carried to other organs. The lungs and liver are therefore common sites of metastases.

 

(3) Many cancers tend to shed cells into the bloodstream early in their course. Most of these cells die in the bloodstream, but some lodge against the surface and penetrate the wall into the tissue. A few may find themselves in a favorable tissue in which they are able to survive and grow into a tumor; this is known as a metastasis. Others may divide only a few times, forming a small nest of cells that then remain dormant as a micrometastasis. They may remain dormant for many years, only to begin to grow again as recurrent cancer, for reasons unknown.

 

Cancer cells even when widely disseminated may retain the physical and biological characteristics of their tissue of origin. Thus a pathologist can often determine the site of origin of metastatic tumors by microscopic examination of the cancerous tissue. Identification of tumors of the endocrine glands is simplified because they may produce excessive amounts of the hormone that is produced by the parent tissue. Such tumors may also respond to administration of the hormones that normally control that tissue.

 

In general, the less closely a cancer resembles its tissue of origin, the more malignant and rapidly invasive it tends to be; however, the rate of growth of a cancer depends not only on cellular type and the degree of dedifferentiation from the tissue of origin, but also on various host factors. A characteristic of malignancy is tumor-cell heterogeneity. Because of the abnormalities of proliferation in tumor cells, they are more susceptible to mutation. With time, a tumor tends to become less differentiated and to grow more rapidly. It may also develop increased resistance to chemotherapy or irradiation.

 

Occurrence

Cancer is the second leading cause of death in adults in the Western world and is one of the leading causes of death from disease in children between the ages of 1 and 14. However despite this it is still rare in young people.

 

For particular cancers, the difference between countries may be as high as 40-fold. Evidence from studies of populations that have migrated from one geographical area to another suggests that these variations are due to differences in lifestyle rather than ethnic origin. This is consistent with other evidence that most cancers are predominately related to environmental causes rather than heredity, although the two may interact.

 

The cancers that cause the most deaths in Europe and the United States are those of the lung, bowel (colorectal), breast, prostate, and stomach. Together they account for about half of cancer deaths. These are also the most common types of cancer along with skin cancer. Skin cancer is the first or second most common cancer in many Western countries such as the United States, Australia, and the United Kingdom. Fortunately, with the exception of malignant melanoma (the rarest and most serious form), skin cancers are rarely fatal.

 

Causes, Prevention, and Early Detection

About 80% of cancers are potentially preventable. The biggest known cause is smoking, which accounts for 30% of deaths from the disease. Although all the causes of cancer are yet to be ascertained, accumulating evidence about the effects of smoking, diet, radiation, hereditary factors, hormones, chemicals and certain types of infection shows that these factors may be involved.

 

It is already known that there are several things people can do to cut the risk of cancer. Everyone should:

 

Avoid getting sunburnt;

Take up offers of cancer screening tests;

Eat a healthy diet;

Only drink moderate amounts of alcohol;

Observe safety rules in jobs where exposure to chemicals, radiation, and other hazards increases risk; and most importantly,

Not smoke.

 

Smoking

Smoking is one of the biggest causes of premature death in the Western world. Not only does it cause over one third of cancers, but it also causes heart disease and major forms of lung disease, such as chronic bronchitis and emphysema. Smoking has already killed 60 million people worldwide since 1950 and is likely to kill half a billion of those alive today unless current habits are changed. Out of 1,000 young adults (if they all smoke) on average 1 will be murdered; 6 will be killed on the roads and 250 will be killed by smoking in middle age alone.

 

Smoking causes 90% of lung cancers. It can also cause cancer in a number of other parts of the body, including the mouth, pharynx, larynx, oesophagus, pancreas, renal pelvis, bladder and cervix.

 

There can be no doubt that giving up smoking brings down the risk. If a person manages to give up smoking before developing cancer (or some other serious disease), most of the risk of dying from smoking-related diseases may be avoided. After ten years the risk will be more than halfway towards that of someone who has never smoked.

 

Diet

Diet is probably linked to about 30-35% of cancers. Many researchers believe that it plays a part in many of the most common cancers, such as those of the breast and bowel. However as yet there is no concrete proof of which elements can cause cancer and which help to protect against it.

 

At the moment evidence suggests a protective role for fruit, vegetables, fiber and certain vitamins. Other factors such as a high-fat or excessive meat diet are thought to increase risk. For instance many researchers think that an increased intake of fresh fruit and vegetables decreases the risk of stomach cancer. People who eat moderate amounts of fruit such as one piece of fruit per day have a substantially lower risk of developing this cancer.

 

Reducing calories from fat to 20% of the diet, cutting down on red meat, increasing dietary fiber (such as wholemeal bread, fruits and vegetables) and eating protective foods (foods that contain vitamins C and A, as well as vegetables such as cabbage, cauliflower, broccoli and Brussels sprouts) all provide benefits. Foods (mainly vegetables) containing beta-carotene, an antioxidant which is converted to vitamin A in the body, are thought to provide some protection against the cell changes that may lead to cancer. Moderation in eating salt-cured, smoked and nitrite-cured foods and in the consumption of alcohol is also advised.

 

Apart from eating a healthy diet, keeping weight down is also an important measure in cutting cancer risk. Obesity increases the risk of breast, bowel, uterus and prostate cancers. Some recent studies have shown that moderate exercise may also play a part in preventing cancer as well as maintaining general good health.

 

Over-consumption of alcohol is responsible for 3% of cancer deaths. Cancers of the mouth, throat and oesophagus are linked to this, with those most at risk being people who drink excessively and smoke cigarettes.

 

Infections

There is growing evidence that some infections are linked to certain cancers. In particular, infections have been found to be involved in cancers of the stomach, liver, cervix and in Kaposi's sarcoma—a rare cancer which is common in AIDS patients.

 

The bacterium Helicobacter pylori may help to cause many cases of stomach cancer. Studies have shown that people infected with the bacterium are four times more likely to develop this cancer.

 

Cervical cancer is linked to two sexually transmitted types of human papilloma virus—HPV-16 and HPV-18. HPV infection is quite common and most women who are infected do not develop cervical cancer. However, it does seem that HPV infection is an extremely important step in the development of the disease—often occurring several years before the appearance of cancer. Research is now under way to find a vaccine against these types of HPV.

 

People who are carriers of some types of viruses are at greatly increased risk of cancer. Childhood infection may be particularly important. When viruses like hepatitis B (which contributes to liver cancer) are contracted at birth or during early childhood, the patient becomes a carrier. In countries like China, where childhood infection with hepatitis B is endemic, rates of liver cancer in adults are high—40-50% of liver cancer in the world occurs in China. Research is under way to see if vaccinating Chinese children against hepatitis B will prevent them from developing liver cancer in later life.

 

Hormones, Radiation, and Occupational Factors

Certain cancers particularly of the breast and prostate have a hormonal link and some medical researchers think that hormones may act as tumor promoters in these cancers. Research is continuing into how the growth of cancer cells may be accelerated by hormones and slowed down by hormone-blocking drugs.

 

As well as being a successful treatment for cancer, radiation can cause cancer. The risk from radiation is related directly to the dose received, and therefore for most people the amount received in a lifetime is relatively small. People who live in areas with high levels of radon, a radioactive gas, are more at risk of developing lung cancer.

 

Ultraviolet (UV) radiation types A and B from sunlight are responsible for most skin cancers. UV is at its strongest during the summer months and people need to protect themselves by not exposing the skin for long periods and by wearing a hat with a wide brim which shades the face; by avoiding exposure to the midday sun; and by applying a high-factor sunscreen of at least SPF15 on exposed skin at regular intervals, especially before and after swimming. These precautions apply equally to summer in European climates as to summer in hotter ones. Particular attention to this problem in Australia has resulted in health campaigns encouraging people to take precautions against sun exposure.

 

Skin cancer rates in Australia are higher than anywhere else in the world. It is the most common form of cancer in Australia, affecting all age groups from adolescents upwards. Most common is basal cell carcinoma (rodent ulcer), which accounts for about 75% of all skin cancers. Squamous cell carcinomas account for 20% and melanoma less than 5%. Two out of three Australians will develop skin cancer—usually a basal cell carcinoma—and about 1 in 60 people will develop a melanoma in his or her lifetime.

 

Certain occupations carry an increased risk of cancer because workers are exposed to hazardous substances such as chemicals, asbestos or radiation. It is therefore very important for work safety procedures to be put in place, to provide as much protection for workers as possible and for workers to follow the guidelines.

 

Hereditary Factors

It is estimated that 5-10% of cancers are inherited and extensive research is being done to find the faulty genes responsible. Some of these genes have already been found; for instance, the genes BRCA1 and BRCA2 are linked to some hereditary breast cancers. Mutations in BRCA1 are also responsible for about 80% of inherited ovarian cancers.

 

 

Detection and Diagnosis

The earlier a cancer is diagnosed and treated the greater the chance is of a cure. Screening is useful for detecting some cancers, but people still need to be aware of symptoms as cancers may occur between screenings and everyone should take notice of the early warning signs of cancers for which there is no screening available. The following list of symptoms warrants attention:

 

Change in bowel or bladder habits.

A sore throat that does not heal.

Unusual bleeding or discharge.

Thickening or lump in the breast or elsewhere.

Indigestion or difficulty in swallowing.

Obvious change in a wart or mole.

Nagging cough or hoarseness.

 

Any of these symptoms, indeed any unexplained lump, pain, weight loss, or lethargy, should be referred to a doctor. Although one or more symptoms may be indicative of something other than cancer, a check-up to confirm their cause is the best course of action.

 

A physical examination for cancer includes inspection and palpation of all accessible sites, especially the skin, neck, breasts, abdomen, testicles, and lymph-node areas. It may include examination of bodily orifices, particularly rectal examination for cancers of the rectum or prostate, and pelvic examination for cancers of the cervix or uterus.

Screening and Self-examination

The earlier a cancer is diagnosed the greater the chance of cure. A monthly check for changes in the way your body looks and feels can help early detection of breast, skin and testicular cancer. Some cancers can be detected at an early or pre-cancerous stage through screening.

 

Cervical screening can detect cervical cancer. More importantly, it can prevent this cancer because it detects pre-cancerous cells. Doctors are now considering ways of improving the screening program—including the possibility of adding a test for HPV-16 to the smear test.

 

Bowel cancer also has a pre-cancerous stage which can be detected by screening. One method under consideration uses a thin flexible tube (a sigmoidoscope) to detect polyps in the bowel which, if left, may turn cancerous. Studies suggest that removing these benign growths will nearly halve a person's risk of cancer for about ten years. Some doctors recommend that screening should begin at a younger age, but recent studies indicate that mammography may not benefit pre-menopausal women because their breast tissue is more dense making mammograms consequently much harder to read.

Biopsy

The biopsy remains the only definitive method for the diagnosis of a cancer. In a biopsy a section of tissue is removed from the tumor itself or from a metastasis. Modern technology has greatly reduced the need for open surgical biopsy. Guided by palpation or a computerized axial tomography (CAT or CT) scan a tumor in almost any part of the body can be biopsied through a thin flexible needle. This permits diagnosis before surgery so that the doctor and patient can better plan for treatment and surgery, if it is necessary.

 

Staging

Once a tissue diagnosis of cancer has been made the extent or stage of the disease must be evaluated because prognosis and appropriate treatment vary with the stage of the disease. For each type of tumor the stage (I, II, III, or IV) is defined in terms of findings with progressively more severe prognostic implications: small local tumor, more extensive local tumor, regional lymph node involvement and distant metastases. The clinical stage, defined by information obtained prior to surgical exploration, is used to decide appropriate initial treatment. The surgical stage, which may be different from the clinical, incorporates the findings of the surgical exploration, and is used as a basis for later treatment and for prognosis. It is also used to analyze the effects of different treatments.

 

Treatment

The traditional means of treating cancer have been surgery, radiation and chemotherapy. However, revolutionary treatments are now under development and researchers are using laboratory discoveries to design drugs that will exploit specific biological processes in cancer.

 

Surgery

The principal approach to curing cancer is to remove all the malignant cells by a surgical operation. In the past this meant the removal of all of the involved tissue and as much potentially involved tissue as possible including adjacent tissues and lymph nodes. For some tumors notably cancer of the breast this radical degree of surgery (mastectomy) is not always necessary. Refinements in surgical techniques improved knowledge of physiology, advances in anesthesia, ready availability of blood products and potent antibiotics have permitted less extensive surgery with more rapid recovery and less resulting disability. Many cancers though are at too advanced a stage at the time of diagnosis to be eradicated by surgery. If local extension involves neighboring tissues that cannot be sacrificed or if distant metastases are already present surgery will not cure the cancer. Even when it is clear that surgical cure is not possible, however, surgery may help to relieve symptoms, such as obstruction, or to reduce the size of the tumor in an effort to improve the patient's response to subsequent radiotherapy or chemotherapy.

 

Radiation Therapy

Ionizing radiation, which may be either electromagnetic or particulate, is destructive to tissue. Electromagnetic radiation includes gamma rays, which are emitted by radioactive decay and X-rays, which are produced when a beam of electrons strikes a heavy-metal target. Particulate radiation includes beams of electrons, protons, neutrons, alpha particles (helium nuclei) and negative pi mesons (pions).

 

Tumors vary greatly in their sensitivity to radiation. A “sensitive” tumor is one that is more sensitive than surrounding normal tissues. When such a tumor is readily accessible—a superficial tumor or one in an organ like the uterus into which a radiation source can be introduced—it may be curable by radiation therapy. Because of its relatively sparing effect on normal tissues, radiation is useful when a tumor cannot be removed because surgery would damage vital adjacent tissue or because it has begun to infiltrate adjacent structures that cannot be sacrificed. Radiation therapy is also extremely useful for palliation (temporary relief) especially of metastatic tumors.

 

Radiation can also be a valuable adjunct to surgery. Pre-operative radiation may rapidly sterilize the tumor cells and prevent them from seeding at surgery. It may also shrink the tumor and make surgery easier or shrink an inoperable tumor so that it becomes operable. In other tumors post-operative radiation is used.

 

Chemotherapy

Chemotherapy is the use of drugs in the treatment of cancer. Since a drug is distributed throughout the body by the bloodstream, chemotherapy is prescribed for tumors that have spread beyond the area accessible by surgery or radiotherapy. A number of different types of anticancer drugs are used, but nearly all work by interfering with DNA synthesis or function. Rapidly dividing cells are therefore more sensitive to chemotherapy. Cancers have a larger proportion of dividing cells than do normal tissues, in which stem, or replenishing, cells are dormant. This means they are more resistant to drug effect than the cancer cells, which proliferate rapidly. The most rapidly proliferating normal cells are in the bone marrow and the cells lining the gastrointestinal tract. These are the most sensitive normal areas likely to be affected by chemotherapy and therefore constitute the sites of toxicity that will limit the tolerable dose of most drugs.

 

Therefore, to be effectively treated a tumor must have a sensitivity greater than that of the most sensitive normal tissue. Some tumors may be many times more sensitive, but many are only slightly more sensitive. Fortunately, the normal bone marrow cells can divide faster than malignant cells and thus recover more rapidly. This permits a repeat cycle of the drug before the tumor has regrown to any great extent. Repeated cycles can steadily deplete a tumor before resistance occurs. Some tumors are so sensitive to chemotherapy that a chemotherapeutic cure is possible in a high percentage: uterine cancer; acute leukemia, especially in children; Hodgkin's disease and diffuse large-cell lymphoma; testicular carcinoma; and several childhood cancers are examples. These cancers have often already spread at the time of diagnosis and cannot be treated by other means. However, other advanced cancers respond well to chemotherapy and can be controlled for a long time, so chemotherapy is commonly used for palliation.

 

Two major problems limiting the usefulness of chemotherapy are toxicity and resistance. Techniques that avoid or control toxicity and reduce the risk of resistance have steadily improved. It is important to begin treatment as early as possible, to use the optimal dose of the drug, and to repeat cycles as quickly as possible, while giving the patient a chance to recover somewhat from toxicity.

 

The use of multiple drugs is effective. Combination chemotherapy employs several drugs (often three to six at a time), each of which is effective as a single agent. The drugs used have different mechanisms of action, making cross-resistance less likely and different types of toxicity, so that each may be given at optimal dose without causing fatal additive toxicity.

 

High doses of chemotherapy can be given if a bone marrow transplant or bone marrow or stem cell rescue is part of the treatment regime. This is most often used in leukemia treatment, but there are trials under way in other cancers.

 

Chemotherapy may be used with surgery or radiation as combined modality therapy. It is often used as an adjuvant, or helper, when surgery is the primary therapy. As such it is usually given after surgery. This type of therapy has greatly increased the cure rate of breast cancer. The major purpose of chemotherapy as an adjuvant is to kill off micrometastases that may have been established before surgery. Recently, chemotherapy has been used before surgery as a neoadjuvant. This therapy has the same effect as adjuvant chemotherapy but may also shrink a tumor making it more easily operable.

 

Hormone Therapy

Many cancers arising from tissues that are hormone-dependent such as the breast, prostate, endometrium (uterine lining) and thyroid are responsive to hormone manipulation. This may consist of removing the source of the stimulating hormone or the administration of various hormones and antihormones.

 

Other Approaches

Several promising new approaches to the treatment of cancer are being taken. In one, biological agents known as biological response modifiers are used to modify the response of the body (particularly the immune system) to cancer. Another approach involves biological agents that stimulate certain cells, which can then attack the malignant cells. The best example is the use of interleukin-2 to stimulate the patient's lymphokine-activated killer lymphocytes (LAK cells). Research is also concerned with tumor-specific antigens against which antibodies could be raised. These anti-tumor antibodies would be used to treat cancer either directly or by coupling to a chemotherapeutic agent. The antibody could identify the malignant cell and stick to it, thus delivering the drug directly to the target.

 

Other New Approaches

Another growing area of research is gene therapy. This employs various methods to introduce genetic material into the cancer to make it more recognizable to the immune system. It can also make the cancer cells more sensitive to drug treatments, or it can place new genes into T-cells to make them more active. Work is under way to develop vaccines by removing cells from the patient and modifying them in the laboratory so that they secrete a protein that stimulates the immune system. The cells are irradiated to stop them dividing, and are then injected into the patient.

 

Even if cured, a cancer patient may be left with serious disabilities. Every effort must be made to achieve the maximum possible quality of life through rehabilitative techniques, including reconstructive surgery. For the patient who is not cured, palliative therapy may achieve comfort and good function for months or years. Pain can be a severe problem, as can depression, but both can be relieved today much more than in the past.